You just read:

Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer

News provided by

Bayer HealthCare , Onyx Pharmaceuticals, Inc.

Jul 25, 2014, 02:30 ET